within Pharmacolibrary.Drugs.ATC.G;

model G02CC01_1
  extends Pharmacokinetic.Models.PK_2C(
    weight         = 70,
    F              = 1,
    Cl             = 1.4999999999999998e-06,
    adminDuration  = 600,
    adminMass      = 400 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.00011,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,            
    Vdp             = 8.999999999999999e-05,
    k12             = 0.16,
    k21             = 0.16
    
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>G02CC01_1</td></tr><td>route:</td><td>intravenous</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Ibuprofen is a non-steroidal anti-inflammatory drug (NSAID) used for the treatment of pain, fever, and inflammation. It is approved and commonly used worldwide for mild to moderate pain, dysmenorrhea, and inflammatory conditions such as arthritis.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported for healthy adult volunteers after single intravenous administration.</p><h4>References</h4><ol><li><p>Atkinson, HC, et al., &amp; Robson, R (2015). Pharmacokinetics and Bioavailability of a Fixed-Dose Combination of Ibuprofen and Paracetamol after Intravenous and Oral Administration. <i>Clinical drug investigation</i> 35(10) 625–632. DOI:<a href=\"https://doi.org/10.1007/s40261-015-0320-8\">10.1007/s40261-015-0320-8</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/26334726/\">https://pubmed.ncbi.nlm.nih.gov/26334726</a></p></li><li><p>Smith, HS, &amp; Voss, B (2012). Pharmacokinetics of intravenous ibuprofen: implications of time of infusion in the treatment of pain and fever. <i>Drugs</i> 72(3) 327–337. DOI:<a href=\"https://doi.org/10.2165/11599230-000000000-00000\">10.2165/11599230-000000000-00000</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/22316349/\">https://pubmed.ncbi.nlm.nih.gov/22316349</a></p></li><li><p>Jin, Y, et al., &amp; Wang, Z (2023). Comparison of intravenous ibuprofen pharmacokinetics between Caucasian and Chinese populations using physiologically based pharmacokinetics modeling and simulation. <i>European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences</i> 191 106587–None. DOI:<a href=\"https://doi.org/10.1016/j.ejps.2023.106587\">10.1016/j.ejps.2023.106587</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/37734467/\">https://pubmed.ncbi.nlm.nih.gov/37734467</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end G02CC01_1;
